Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Other Working Capital Changes data on record, last reported at -$76000.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 272.73% year-over-year to -$76000.0; the TTM value through Sep 2025 reached -$100000.0, up 58.33%, while the annual FY2024 figure was -$21000.0, 94.21% up from the prior year.
  • Other Working Capital Changes reached -$76000.0 in Q3 2025 per CYCN's latest filing, down from $206000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.2 million in Q4 2021 and bottomed at -$998000.0 in Q3 2021.
  • Average Other Working Capital Changes over 5 years is -$25294.1, with a median of -$65000.0 recorded in 2024.
  • Peak YoY movement for Other Working Capital Changes: soared 175.83% in 2023, then plummeted 272.73% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.2 million in 2021, then tumbled by 112.33% to -$143000.0 in 2022, then crashed by 98.6% to -$284000.0 in 2023, then surged by 77.11% to -$65000.0 in 2024, then decreased by 16.92% to -$76000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$76000.0 in Q3 2025, $206000.0 in Q2 2025, and -$165000.0 in Q1 2025.